Available in all Walmart Logo Pharmacy and Sporting Goods Departments
BleedStop™ logo
Call us now! 651.964.6461

Image of BleedStop™ Study, available on request
This animal study, conducted by five independent medical doctors, was performed on swine by completely severing femoral arteries. The results were peer reviewed, it was presented at a major medical conference, and it has been published in a major medical journal.

While all ten pigs survived with BleedStop™, by posting this study, BleedStop™ and CoAg Medical are in no way suggesting that the FDA has approved our product for use on arteries in humans. BleedStop™ has been approved for severe bleeding wounds for humans by the FDA with an Rx Prescription. If a doctor chooses to use BleedStop™ for an arterial bleeding application on a human, which is an off-label use, he or she may choose to do so.
Image of pig with severed femoral artery
Also Tested by the United Arab Emirates Zayed Military Base and the Egyptian Military | Utilized by the largest trauma center in Iraq

FDA Cleared

"Safe in the Wound"

NAMSA GLP Independent Laboratory Animal Study

(Full Study is Available)
Image of FDA Cleared 'Safe in the Wound' study
“The in-life assessment for each animal was clinically normal upon entering the study and all animals remained healthy during the in-life portion of the study. There were two minor health observations (post-operative swelling & inappetence) and no adverse events noted during the study. According to the physical examinations, the clinical pathology results, the daily observations, the procedures, and the in-life assessment all animals in this study demonstrated adequate health to assess the objective of the study.”

To paraphrase the summary, other than surgical swelling at a couple of the sites and temporary loss of appetite after the surgery, all animals observed after the 4-week period were in the same condition as they were when they started. The StopsBleeding™/BleedStop™ powder in the animals' bodies had no adverse effect on any of the three animals or in any of the 12 sites.

“Mild post-operative inflammation was noted in all 3 animals, which is normal post-operative sequella. These conditions were treated with additional analgesic medications (ibuprofen & meloxicam SR) and jackets to protect the integrity of the implant sites. Mild inappetence was noted briefly in all animals, which is to be expected after a procedure. All the animals in this study were otherwise healthy throughout the in-life portion of the study.”

StopsBleeding™ and BleedStop™ are trade names of CoAg Medical LLC for their hemostatic powder and rigid foam products. Both products, StopsBleeding™ and BleedStop™, are identical except for the name. In general, BleedStop™ is marketed to consumers, and StopsBleeding™ is marketed to hospitals.